Thanks to advancements in cell biology, proteomics, and genomics, the market for single cell analysis is growing dramatically. The market, valued at billions of dollars, is expected to rise at a strong compound annual growth rate (CAGR) over the forecast period. Due to advancements in single-cell sequencing, the rising incidence of chronic illnesses, and the increasing need for customized drugs, the market is developing.